Glp 1 News

The use of GLP-1 drugs in US children under 12 has significantly increased, despite lacking FDA approval for this age group, amidst concerns that one in five ch

In 1992, Dr. John Eng discovered a molecule in Gila monster venom, which later paved the way for widely used type 2 diabetes medicines like exenatide.

A Zomato-listed cloud kitchen offering 'GLP-1 friendly and high protein' meals has gone viral, sparking debate on whether such specialized menus genuinely aid t

The U.S. Food and Drug Administration (FDA) has approved Mounjaro to reduce the risk of heart events, including heart attacks, in individuals with diabetes. Dev

A new Medicare pilot program offering GLP-1 medications for weight loss at $50 a month is excluding some patients, like Jeff La Marca, who have pre-existing con

US nutrition startup Berry Street has merged with India's Healthify, with founders Noah Kotlove and Tushar Vashisht becoming co-CEOs of the new entity, as GLP-1

A new daily pill called Foundayo, which treats diabetes and aids weight loss, is now available in UK pharmacies via private prescription. Pharmacists welcome th

The increasing popularity of GLP-1 drugs is leading to a growing market for managing their side effects.

Nestle is developing specialized products for users of GLP-1 weight-loss drugs, utilizing artificial intelligence to identify nutrient combinations. These new o

A Harvard economist's research indicates that taking GLP-1 weight-loss drugs significantly increased unemployed women's chances of securing a job.

More than 150 deaths have been reported following the use of weight loss drugs, with most complaints to the MHRA's Yellow Card scheme concerning gastrointestina

The rising demand for GLP-1 obesity medications is fueling a significant increase in the need for nutrition professionals across India. Hospitals and digital he

A recent clinical trial found that individuals with alcohol use disorder who took oral semaglutide, a daily GLP-1 pill, showed significant improvements compared

RenaissThera, a Bengaluru-based company founded in 2023, is developing oral small-molecule drugs for obesity and type 2 diabetes, focusing on targets like GLP-1

Cipla is prioritizing its tirzepatide brand Yurpeak in the Indian obesity market, which has become the second-largest GLP-1 product since its launch. The compan

A new study suggests that GLP-1 use, including drugs like Ozempic, is rapidly increasing among teenagers and young adults for weight loss, potentially displacin

Novo Nordisk has filed a lawsuit against Eli Lilly, accusing its GLP-1 rival of using outdated data in its advertising campaigns.

Wegovy has been approved by the drug regulator as the first GLP-1 medication for adults suffering from fatty liver disease.

Users of GLP-1 weight-loss drugs in the UK and US are changing their spending habits and wardrobes as they slim down, exemplified by Hayley Grice, who dropped s

A comprehensive study of 19 obesity drugs indicates that while weight loss gains are clear, no single GLP-1 or other weight loss drug is a universal winner. The